|
US4057685A
(en)
|
1972-02-02 |
1977-11-08 |
Abbott Laboratories |
Chemically modified endotoxin immunizing agent
|
|
DE2848965A1
(de)
|
1978-11-11 |
1980-05-22 |
Behringwerke Ag |
Verfahren zur herstellung von membranproteinen aus neisseria meningitidis und diese enthaltende vaccine
|
|
AU545912B2
(en)
|
1980-03-10 |
1985-08-08 |
Cetus Corporation |
Cloned heterologous jive products in bacillies
|
|
ZA811368B
(en)
|
1980-03-24 |
1982-04-28 |
Genentech Inc |
Bacterial polypedtide expression employing tryptophan promoter-operator
|
|
NO821391L
(no)
|
1981-04-29 |
1982-11-01 |
Biogen Nv |
Kloningsvektorer, rekombinante dna-molekyler samt bakterieverter transformert med disse
|
|
US4551433A
(en)
|
1981-05-18 |
1985-11-05 |
Genentech, Inc. |
Microbial hybrid promoters
|
|
US4356170A
(en)
|
1981-05-27 |
1982-10-26 |
Canadian Patents & Development Ltd. |
Immunogenic polysaccharide-protein conjugates
|
|
US4673574A
(en)
|
1981-08-31 |
1987-06-16 |
Anderson Porter W |
Immunogenic conjugates
|
|
SE8205892D0
(sv)
|
1982-10-18 |
1982-10-18 |
Bror Morein |
Immunogent membranproteinkomplex, sett for framstellning och anvendning derav som immunstimulerande medel och sasom vaccin
|
|
US4459286A
(en)
|
1983-01-31 |
1984-07-10 |
Merck & Co., Inc. |
Coupled H. influenzae type B vaccine
|
|
JPS59166086A
(ja)
|
1983-03-09 |
1984-09-19 |
Teruhiko Beppu |
新規な発現型プラスミドとそれらを用いて仔牛プロキモシン遺伝子を大腸菌内で発現させる方法
|
|
US4663160A
(en)
|
1983-03-14 |
1987-05-05 |
Miles Laboratories, Inc. |
Vaccines for gram-negative bacteria
|
|
JPS59205983A
(ja)
|
1983-04-28 |
1984-11-21 |
ジエネツクス・コ−ポレイシヨン |
異種遺伝子を原核微生物で発現させる方法
|
|
US4663280A
(en)
|
1983-05-19 |
1987-05-05 |
Public Health Research Institute Of The City Of New York |
Expression and secretion vectors and method of constructing vectors
|
|
US4761283A
(en)
|
1983-07-05 |
1988-08-02 |
The University Of Rochester |
Immunogenic conjugates
|
|
US4689406A
(en)
|
1983-08-10 |
1987-08-25 |
Amgen |
Enhancement of microbial expression of polypeptides
|
|
JPS6054685A
(ja)
|
1983-09-02 |
1985-03-29 |
Suntory Ltd |
改良発現ベクタ−およびその利用
|
|
EP0136907A3
(en)
|
1983-10-03 |
1986-12-30 |
Genentech, Inc. |
A xenogeneic expression control system, a method of using it, expression vectors containing it, cells transformed thereby and heterologous proteins produced therefrom
|
|
US5916588A
(en)
|
1984-04-12 |
1999-06-29 |
The Liposome Company, Inc. |
Peptide-containing liposomes, immunogenic liposomes and methods of preparation and use
|
|
US6090406A
(en)
|
1984-04-12 |
2000-07-18 |
The Liposome Company, Inc. |
Potentiation of immune responses with liposomal adjuvants
|
|
US4882317A
(en)
|
1984-05-10 |
1989-11-21 |
Merck & Co., Inc. |
Covalently-modified bacterial polysaccharides, stable covalent conjugates of such polysaccharides and immunogenic proteins with bigeneric spacers and methods of preparing such polysaccharides and conjugataes and of confirming covalency
|
|
US4695624A
(en)
|
1984-05-10 |
1987-09-22 |
Merck & Co., Inc. |
Covalently-modified polyanionic bacterial polysaccharides, stable covalent conjugates of such polysaccharides and immunogenic proteins with bigeneric spacers, and methods of preparing such polysaccharides and conjugates and of confirming covalency
|
|
US4808700A
(en)
|
1984-07-09 |
1989-02-28 |
Praxis Biologics, Inc. |
Immunogenic conjugates of non-toxic E. coli LT-B enterotoxin subunit and capsular polymers
|
|
US4738921A
(en)
|
1984-09-27 |
1988-04-19 |
Eli Lilly And Company |
Derivative of the tryptophan operon for expression of fused gene products
|
|
US4745056A
(en)
|
1984-10-23 |
1988-05-17 |
Biotechnica International, Inc. |
Streptomyces secretion vector
|
|
IT1187753B
(it)
|
1985-07-05 |
1987-12-23 |
Sclavo Spa |
Coniugati glicoproteici ad attivita' immunogenica trivalente
|
|
US4865974A
(en)
|
1985-09-20 |
1989-09-12 |
Cetus Corporation |
Bacterial methionine N-terminal peptidase
|
|
JPS63123383A
(ja)
|
1986-11-11 |
1988-05-27 |
Mitsubishi Kasei Corp |
ハイブリツドプロモ−タ−、発現調節ｄｎａ配列および発現ベクタ−
|
|
US5057540A
(en)
|
1987-05-29 |
1991-10-15 |
Cambridge Biotech Corporation |
Saponin adjuvant
|
|
JPH01125328A
(ja)
|
1987-07-30 |
1989-05-17 |
Centro Natl De Biopreparados |
髄膜炎菌ワクチン
|
|
NL8802046A
(nl)
|
1988-08-18 |
1990-03-16 |
Gen Electric |
Polymeermengsel met polyester en alkaansulfonaat, daaruit gevormde voorwerpen.
|
|
NZ230423A
(en)
|
1988-08-25 |
1993-08-26 |
Liposome Co Inc |
A dosage form comprising an antigen and a multilamellar liposome comprising dimyristolyphosphatidylcholine (dmpc) and cholesterol
|
|
DE3841091A1
(de)
|
1988-12-07 |
1990-06-13 |
Behringwerke Ag |
Synthetische antigene, verfahren zu ihrer herstellung und ihre verwendung
|
|
JP3436756B2
(ja)
|
1988-12-19 |
2003-08-18 |
アメリカン・サイアナミド・カンパニー |
髄膜炎菌のクラスｉの外膜タンパク質のワクチン
|
|
CA2006700A1
(en)
|
1989-01-17 |
1990-07-17 |
Antonello Pessi |
Synthetic peptides and their use as universal carriers for the preparation of immunogenic conjugates suitable for the development of synthetic vaccines
|
|
HU212924B
(en)
|
1989-05-25 |
1996-12-30 |
Chiron Corp |
Adjuvant formulation comprising a submicron oil droplet emulsion
|
|
EP0482068A1
(en)
|
1989-07-14 |
1992-04-29 |
American Cyanamid Company |
Cytokine and hormone carriers for conjugate vaccines
|
|
IT1237764B
(it)
|
1989-11-10 |
1993-06-17 |
Eniricerche Spa |
Peptidi sintetici utili come carriers universali per la preparazione di coniugati immunogenici e loro impiego per lo sviluppo di vaccini sintetici.
|
|
SE466259B
(sv)
|
1990-05-31 |
1992-01-20 |
Arne Forsgren |
Protein d - ett igd-bindande protein fraan haemophilus influenzae, samt anvaendning av detta foer analys, vacciner och uppreningsaendamaal
|
|
ATE128628T1
(de)
|
1990-08-13 |
1995-10-15 |
American Cyanamid Co |
Faser-hemagglutinin von bordetella pertussis als träger für konjugierten impfstoff.
|
|
IT1262896B
(it)
|
1992-03-06 |
1996-07-22 |
|
Composti coniugati formati da proteine heat shock (hsp) e oligo-poli- saccaridi, loro uso per la produzione di vaccini.
|
|
CA2138997C
(en)
|
1992-06-25 |
2003-06-03 |
Jean-Paul Prieels |
Vaccine composition containing adjuvants
|
|
IL102687A
(en)
|
1992-07-30 |
1997-06-10 |
Yeda Res & Dev |
Conjugates of poorly immunogenic antigens and synthetic pepide carriers and vaccines comprising them
|
|
NL9201716A
(nl)
|
1992-10-02 |
1994-05-02 |
Nederlanden Staat |
Buitenmembraanvesikel dat voorzien is van een groep polypeptiden welke ten minste de immuunwerking van aan membraan gebonden buitenmembraaneiwitten (OMP's) hebben, werkwijze ter bereiding ervan alsmede een vaccin dat een dergelijk buitenmembraanvesikel omvat.
|
|
EP0812593B8
(en)
|
1993-03-23 |
2010-11-10 |
SmithKline Beecham Biologicals S.A. |
Vaccine compositions containing 3-0 deacylated monophosphoryl lipid a
|
|
CA2171942C
(en)
|
1993-09-22 |
2010-12-14 |
Andrew Lees |
Method of activating soluble carbohydrate using novel cyanylating reagents for the production of immunogenic constructs
|
|
GB9326174D0
(en)
|
1993-12-22 |
1994-02-23 |
Biocine Sclavo |
Mucosal adjuvant
|
|
GB9326253D0
(en)
|
1993-12-23 |
1994-02-23 |
Smithkline Beecham Biolog |
Vaccines
|
|
US6239116B1
(en)
|
1994-07-15 |
2001-05-29 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
|
US6207646B1
(en)
|
1994-07-15 |
2001-03-27 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
|
US6429199B1
(en)
|
1994-07-15 |
2002-08-06 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules for activating dendritic cells
|
|
AUPM873294A0
(en)
|
1994-10-12 |
1994-11-03 |
Csl Limited |
Saponin preparations and use thereof in iscoms
|
|
IL117483A
(en)
|
1995-03-17 |
2008-03-20 |
Bernard Brodeur |
MENINGITIDIS NEISSERIA shell protein is resistant to proteinase K.
|
|
UA56132C2
(uk)
|
1995-04-25 |
2003-05-15 |
Смітклайн Бічем Байолоджікалс С.А. |
Композиція вакцини (варіанти), спосіб стабілізації qs21 відносно гідролізу (варіанти), спосіб приготування композиції вакцини
|
|
US6180111B1
(en)
|
1995-05-18 |
2001-01-30 |
University Of Maryland |
Vaccine delivery system
|
|
GB9513261D0
(en)
|
1995-06-29 |
1995-09-06 |
Smithkline Beecham Biolog |
Vaccines
|
|
US6558677B2
(en)
|
1996-10-15 |
2003-05-06 |
Wendell D. Zollinger |
Vaccine against gram negative bacteria
|
|
WO1998040100A1
(en)
|
1997-03-10 |
1998-09-17 |
Ottawa Civic Loeb Research Institute |
USE OF NUCLEIC ACIDS CONTAINING UNMETHYLATED CpG DINUCLEOTIDE AS AN ADJUVANT
|
|
US6818222B1
(en)
|
1997-03-21 |
2004-11-16 |
Chiron Corporation |
Detoxified mutants of bacterial ADP-ribosylating toxins as parenteral adjuvants
|
|
GB9711964D0
(en)
|
1997-06-09 |
1997-08-06 |
Medical Res Council |
Live attenuated vaccines
|
|
GB9712347D0
(en)
|
1997-06-14 |
1997-08-13 |
Smithkline Beecham Biolog |
Vaccine
|
|
GB9713156D0
(en)
|
1997-06-20 |
1997-08-27 |
Microbiological Res Authority |
Vaccines
|
|
ATE384130T1
(de)
|
1997-08-21 |
2008-02-15 |
Nederlanden Staat |
Neue mutanten der gram-negativen mukosalen bakterien und ihre verwendung als impfstoffe
|
|
EP1279401B1
(en)
|
1997-09-05 |
2008-01-09 |
GlaxoSmithKline Biologicals S.A. |
Oil in water emulsions containing saponins
|
|
EP2278006A3
(en)
|
1997-11-06 |
2011-03-02 |
Novartis Vaccines and Diagnostics S.r.l. |
Neisserial antigens
|
|
GB9725084D0
(en)
|
1997-11-28 |
1998-01-28 |
Medeva Europ Ltd |
Vaccine compositions
|
|
DK1047784T4
(en)
|
1998-01-14 |
2015-06-15 |
Novartis Vaccines & Diagnostic |
NEISSERA meningitidis ANTIGENS
|
|
JP2002502882A
(ja)
|
1998-02-12 |
2002-01-29 |
アメリカン・サイアナミド・カンパニー |
インターロイキン−１２とともに処方された肺炎球菌および髄膜炎菌のワクチン
|
|
US6303114B1
(en)
|
1998-03-05 |
2001-10-16 |
The Medical College Of Ohio |
IL-12 enhancement of immune responses to T-independent antigens
|
|
TR200002930T2
(tr)
|
1998-04-09 |
2000-12-21 |
Smithkline Beecham Biologicals S.A. |
Kolaylaştırıcı kompozisyonlar
|
|
MX343752B
(es)
|
1998-05-01 |
2016-11-22 |
Novartis Vaccines & Diagnostics Inc |
Antigenos de neisseria meningitidis y composiciones que los contienen.
|
|
US6562798B1
(en)
|
1998-06-05 |
2003-05-13 |
Dynavax Technologies Corp. |
Immunostimulatory oligonucleotides with modified bases and methods of use thereof
|
|
GB9817052D0
(en)
|
1998-08-05 |
1998-09-30 |
Smithkline Beecham Biolog |
Vaccine
|
|
WO2000010599A2
(en)
|
1998-08-19 |
2000-03-02 |
North American Vaccine, Inc. |
IMMUNOGENIC β-PROPIONAMIDO-LINKED POLYSACCHARIDE PROTEIN CONJUGATE USEFUL AS A VACCINE PRODUCED USING AN N-ACRYLOYLATED POLYSACCHARIDE
|
|
US7357936B1
(en)
|
1998-10-16 |
2008-04-15 |
Smithkline Beecham Biologicals, Sa |
Adjuvant systems and vaccines
|
|
EP1123403A1
(en)
|
1998-10-22 |
2001-08-16 |
The University Of Montana |
OMP85 PROTEINS OF $i(NEISSERIA GONORRHOEAE) AND $i(NEISSERIA MENINGITIDIS), COMPOSITIONS CONTAINING SAME AND METHODS OF USE THEREOF
|
|
GB9823978D0
(en)
|
1998-11-02 |
1998-12-30 |
Microbiological Res Authority |
Multicomponent meningococcal vaccine
|
|
AU1626199A
(en)
|
1998-12-04 |
2000-06-26 |
Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The |
A vi-repa conjugate vaccine for immunization against salmonella typhi
|
|
EP1162999B1
(en)
|
1999-03-19 |
2006-11-29 |
Glaxosmithkline Biologicals S.A. |
Vaccine against Streptococcus pneumoniae
|
|
CA2365914A1
(en)
|
1999-04-09 |
2000-10-19 |
Techlab, Inc. |
Recombinant clostridium toxin a protein carrier for polysaccharide conjugate vaccines
|
|
GB9918319D0
(en)
|
1999-08-03 |
1999-10-06 |
Smithkline Beecham Biolog |
Vaccine composition
|
|
IL148672A0
(en)
|
1999-09-24 |
2002-09-12 |
Smithkline Beecham Biolog |
Use of combination of polyxyethylene sorbitan ester and octoxynol as adjuvant and its use in vaccines
|
|
AU766635B2
(en)
|
1999-09-24 |
2003-10-23 |
Smithkline Beecham Biologicals (Sa) |
Adjuvant comprising a polyxyethylene alkyl ether or ester and at least one nonionic surfactant
|
|
GB9925559D0
(en)
|
1999-10-28 |
1999-12-29 |
Smithkline Beecham Biolog |
Novel method
|
|
AU1917501A
(en)
|
1999-11-12 |
2001-06-06 |
University Of Iowa Research Foundation, The |
Control of neisserial membrane synthesis
|
|
JP3701826B2
(ja)
|
1999-11-12 |
2005-10-05 |
株式会社村上開明堂 |
有色防曇鏡
|
|
BR0015961A
(pt)
|
1999-11-29 |
2003-06-10 |
Chiron Spa |
Antìgeno de neisseria de 85kda
|
|
NZ520466A
(en)
|
2000-01-17 |
2003-09-26 |
Chiron S |
Outer membrane vesicle (OMV) vaccine comprising n. meningitidis serogroup B outer membrane proteins
|
|
AU3108001A
(en)
|
2000-01-20 |
2001-12-24 |
Coley Pharmaceutical Group, Inc. |
Immunostimulatory nucleic acids for inducing a th2 immune response
|
|
JP2003523208A
(ja)
|
2000-01-25 |
2003-08-05 |
ザ ユニバーシティ オブ クイーンズランド |
髄膜炎菌表面抗原ＮｈｈＡの保存領域を含むタンパク質
|
|
ATE503837T1
(de)
|
2000-02-28 |
2011-04-15 |
Novartis Vaccines & Diagnostic |
Hybride expression neisserscher proteine
|
|
GB0007432D0
(en)
|
2000-03-27 |
2000-05-17 |
Microbiological Res Authority |
Proteins for use as carriers in conjugate vaccines
|
|
NO20002828D0
(no)
|
2000-06-02 |
2000-06-02 |
Statens Inst For Folkehelse |
Proteinholdig vaksine mot Neisseria meningtidis serogruppe samt fremgangsmÕte ved fremstilling derav
|
|
WO2002009643A2
(en)
|
2000-07-27 |
2002-02-07 |
Children's Hospital & Research Center At Oakland |
Vaccines for broad spectrum protection against diseases caused by neisseria meningitidis
|
|
GB0103170D0
(en)
|
2001-02-08 |
2001-03-28 |
Smithkline Beecham Biolog |
Vaccine composition
|
|
DE60132471T2
(de)
|
2000-09-26 |
2009-01-15 |
Idera Pharmaceuticals, Inc., Cambridge |
Modulation der immunostimulatorischen aktivität von immunostimulierenden oligonukleotidanaloga durch positionelle chemische veränderungen
|
|
EP1328543B1
(en)
|
2000-10-27 |
2009-08-12 |
Novartis Vaccines and Diagnostics S.r.l. |
Nucleic acids and proteins from streptococcus groups a & b
|
|
GB0103171D0
(en)
|
2001-02-08 |
2001-03-28 |
Smithkline Beecham Biolog |
Vaccine composition
|
|
GB0103169D0
(en)
|
2001-02-08 |
2001-03-28 |
Smithkline Beecham Biolog |
Vaccine composition
|
|
US20030035806A1
(en)
|
2001-05-11 |
2003-02-20 |
D'ambra Anello J. |
Novel meningitis conjugate vaccine
|
|
GB0115176D0
(en)
|
2001-06-20 |
2001-08-15 |
Chiron Spa |
Capular polysaccharide solubilisation and combination vaccines
|
|
CN100350972C
(zh)
|
2001-07-26 |
2007-11-28 |
启龙股份公司 |
含有铝佐剂和组氨酸的疫苗
|
|
GB0121591D0
(en)
|
2001-09-06 |
2001-10-24 |
Chiron Spa |
Hybrid and tandem expression of neisserial proteins
|
|
WO2003024480A2
(en)
|
2001-09-14 |
2003-03-27 |
Cytos Biotechnology Ag |
In vivo activation of antigen presenting cells for enhancement of immune responses induced by virus like particles
|
|
AU2002339224B2
(en)
|
2001-09-14 |
2008-10-09 |
Kuros Us Llc |
Packaging of immunostimulatory substances into virus-like particles: method of preparation and use
|
|
MX339524B
(es)
|
2001-10-11 |
2016-05-30 |
Wyeth Corp |
Composiciones inmunogenicas novedosas para la prevencion y tratamiento de enfermedad meningococica.
|
|
WO2003035836A2
(en)
|
2001-10-24 |
2003-05-01 |
Hybridon Inc. |
Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5' ends
|
|
GB0130123D0
(en)
|
2001-12-17 |
2002-02-06 |
Microbiological Res Agency |
Outer membrane vesicle vaccine and its preparation
|
|
WO2003080678A1
(en)
|
2002-03-26 |
2003-10-02 |
Chiron Srl |
Modified saccharides having improved stability in water
|
|
DE20321889U1
(de)
|
2002-08-02 |
2012-03-12 |
Glaxosmithkline Biologicals S.A. |
Impfstoffzusammensetzung
|
|
GB0220194D0
(en)
|
2002-08-30 |
2002-10-09 |
Chiron Spa |
Improved vesicles
|
|
ATE492288T1
(de)
|
2002-10-11 |
2011-01-15 |
Novartis Vaccines & Diagnostic |
Polypeptidimpstoffe zum breiten schutz gegen hypervirulente meningokokken-linien
|
|
ATE466875T1
(de)
|
2002-11-15 |
2010-05-15 |
Novartis Vaccines & Diagnostic |
Unerwartete oberflächenproteine in neisseria meningitidis
|
|
GB0227346D0
(en)
|
2002-11-22 |
2002-12-31 |
Chiron Spa |
741
|
|
MXPA05011110A
(es)
|
2003-04-16 |
2006-01-24 |
Wyeth Corp |
Composiciones inmunogenicas novedosas para la prevencion y tratamiento de un padecimiento originado por meningococos.
|
|
GB0316560D0
(en)
|
2003-07-15 |
2003-08-20 |
Chiron Srl |
Vesicle filtration
|
|
GB0419408D0
(en)
|
2004-09-01 |
2004-10-06 |
Chiron Srl |
741 chimeric polypeptides
|
|
MX2007008785A
(es)
*
|
2005-01-27 |
2008-02-15 |
Childrens Hosp & Res Ct Oak |
Vacunas de vesicula basadas en gna1870 para proteccion de amplio espectro contra padecimientos causados por neisseria meningitidis.
|
|
GB0524066D0
(en)
*
|
2005-11-25 |
2006-01-04 |
Chiron Srl |
741 ii
|
|
AU2007263531B2
(en)
*
|
2006-06-29 |
2012-03-15 |
J. Craig Venter Institute, Inc. |
Polypeptides from neisseria meningitidis
|
|
US9579372B2
(en)
|
2008-02-21 |
2017-02-28 |
Glaxosmithkline Biologicals Sa |
Meningococcal fHBP polypeptides
|
|
US8470340B2
(en)
*
|
2008-09-03 |
2013-06-25 |
Children's Hospital & Research Center Oakland |
Peptides presenting an epitope of a domain of factor H binding protein and methods of use
|
|
GB0819633D0
(en)
*
|
2008-10-25 |
2008-12-03 |
Isis Innovation |
Composition
|